NEWS
LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases

Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories

We are sponsoring the Accelerate@Babraham initiative @BabrahamUK Research Campus, mentoring #StartUps to boost new… https://t.co/u1Hh6WTDii
  • All
  • News Releases
  • Articles & blogs
  • Announcements
  • Events
    • News Releases
    29 August 2019
    LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
    News Releases
    24 June 2019
    Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
    News Releases
    14 June 2019
    LifeArc invests £1.5 million in Ducentis BioTherapeutics
    News Releases
    20 May 2019
    LifeArc monetises Keytruda® royalty interests to fund further research and investment
    News Releases
    9 May 2019
    Medicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology
    News Releases
    24 April 2019
    LifeArc and The University of Kent collaborate to develop potential pain medicines
    News Releases
    16 April 2019
    LifeArc licenses lead stage molecules to Daiichi Sankyo
    News Releases
    27 March 2019
    Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance
    News Releases
    18 January 2019
    EB 2020 London – Save the date